Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery.
Anastomotic leakage
Complications
Fluid overload
Fluid restriction
Ovarian cancer
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
08 Oct 2024
08 Oct 2024
Historique:
received:
10
06
2024
accepted:
10
09
2024
medline:
9
10
2024
pubmed:
9
10
2024
entrez:
8
10
2024
Statut:
aheadofprint
Résumé
Fluid overload and hypovolemia promote postoperative complications in patients undergoing cytoreductive surgery for ovarian cancer. In the present study, postoperative complications and anastomotic leakage were investigated before and after implementation of pulse pressure variation-guided fluid management (PPVGFM) during ovarian cancer surgery. A total of n = 243 patients with ovarian cancer undergoing cytoreductive surgery at the University Hospital Bonn were retrospectively evaluated. Cohort A (CA; n = 185 patients) was treated before and cohort B (CB; n = 58 patients) after implementation of PPVGFM. Both cohorts were compared regarding postoperative complications. Ultrasevere complications (G4/G5) were exclusively present in CA (p = 0.0025). No difference between cohorts was observed regarding severe complications (G3-G5) (p = 0.062). Median positive fluid excess was lower in CB (p = 0.001). This was independent of tumor load [peritoneal cancer index] (p = 0.001) and FIGO stage (p = 0.001). Time to first postoperative defecation was shorter in CB (CB: d2 median versus CA: d3 median; p = 0.001). CB had a shorter length of hospital stay (p = 0.003), less requirement of intensive medical care (p = 0.001) and postoperative ventilation (p = 0.001). CB received higher doses of noradrenalin (p = 0.001). In the combined study cohort, there were more severe complications (G3-G5) in the case of a PFE ≥ 3000 ml (p = 0.034) and significantly more anastomotic leakage in the case of a PFE ≥ 4000 ml (p = 0.006). Intraoperative fluid reduction in ovarian cancer surgery according to a PPVGFM is safe and significantly reduces ultrasevere postoperative complications. PFEs of ≥ 3000 ml and ≥ 4000 ml were identified as cutoffs for significantly more severe complications and anastomotic leakage, respectively.
Sections du résumé
BACKGROUND
BACKGROUND
Fluid overload and hypovolemia promote postoperative complications in patients undergoing cytoreductive surgery for ovarian cancer. In the present study, postoperative complications and anastomotic leakage were investigated before and after implementation of pulse pressure variation-guided fluid management (PPVGFM) during ovarian cancer surgery.
PATIENTS AND METHODS
METHODS
A total of n = 243 patients with ovarian cancer undergoing cytoreductive surgery at the University Hospital Bonn were retrospectively evaluated. Cohort A (CA; n = 185 patients) was treated before and cohort B (CB; n = 58 patients) after implementation of PPVGFM. Both cohorts were compared regarding postoperative complications.
RESULTS
RESULTS
Ultrasevere complications (G4/G5) were exclusively present in CA (p = 0.0025). No difference between cohorts was observed regarding severe complications (G3-G5) (p = 0.062). Median positive fluid excess was lower in CB (p = 0.001). This was independent of tumor load [peritoneal cancer index] (p = 0.001) and FIGO stage (p = 0.001). Time to first postoperative defecation was shorter in CB (CB: d2 median versus CA: d3 median; p = 0.001). CB had a shorter length of hospital stay (p = 0.003), less requirement of intensive medical care (p = 0.001) and postoperative ventilation (p = 0.001). CB received higher doses of noradrenalin (p = 0.001). In the combined study cohort, there were more severe complications (G3-G5) in the case of a PFE ≥ 3000 ml (p = 0.034) and significantly more anastomotic leakage in the case of a PFE ≥ 4000 ml (p = 0.006).
CONCLUSIONS
CONCLUSIONS
Intraoperative fluid reduction in ovarian cancer surgery according to a PPVGFM is safe and significantly reduces ultrasevere postoperative complications. PFEs of ≥ 3000 ml and ≥ 4000 ml were identified as cutoffs for significantly more severe complications and anastomotic leakage, respectively.
Identifiants
pubmed: 39379788
doi: 10.1245/s10434-024-16246-0
pii: 10.1245/s10434-024-16246-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clinic. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660 .
doi: 10.3322/caac.21660
Du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO‐OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer. 2009;115(6):1234–44. https://doi.org/10.1002/cncr.24149 .
doi: 10.1002/cncr.24149
pubmed: 19189349
Harter P, Sehouli J, Vergote I, Ferron G, Reuss A, Meier W, Greggi S, Mosgaard BJ, Selle F, Guyon F, Pomel C. Randomized trial of cytoreductive surgery for relapsed ovarian cancer. New England J Med. 2021;385(23):2123–31. https://doi.org/10.1056/NEJMOA2103294 .
doi: 10.1056/NEJMOA2103294
Wimberger P, Wehling M, Lehmann N, et al. Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group). Ann Surg Oncol. 2010. https://doi.org/10.1245/S10434-010-0964-9 .
doi: 10.1245/S10434-010-0964-9
pubmed: 20165986
Kuusela K, Norppa N, Auranen A, Saarelainen S. Maximal surgical effort increases the risk of postoperative complications in the treatment of advanced ovarian cancer. Eur J Surg Oncol. 2022. https://doi.org/10.1016/J.EJSO.2022.06.007 .
doi: 10.1016/J.EJSO.2022.06.007
pubmed: 35717320
Egger EK, Merker F, Ralser DJ, et al. Postoperative paralytic ileus following debulking surgery in ovarian cancer patients. Front Surg. 2022. https://doi.org/10.3389/FSURG.2022.976497 .
doi: 10.3389/FSURG.2022.976497
pubmed: 36090332
Egger EK, Kohls K, Stope MB, et al. risk factors for severe complications in ovarian cancer surgery. In Vivo. 2020;34(6):3361–5. https://doi.org/10.21873/invivo.12174 .
doi: 10.21873/invivo.12174
pubmed: 33144443
Aletti GD, Santillan A, Eisenhauer MEL, et al. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model. Gynecol Oncol. 2020;107(1):99–106. https://doi.org/10.1016/j.ygyno.2007.05.032 .
doi: 10.1016/j.ygyno.2007.05.032
Grass F, Lovely JK, Crippa J, Hübner M, Mathis KL, Larson DW. Potential association between perioperative fluid management and occurrence of postoperative ileus. Diseases Colon Rectum. 2020;63(1):68–74. https://doi.org/10.1097/DCR.0000000000001522 .
doi: 10.1097/DCR.0000000000001522
Grass F, Pache B, Butti F, et al. Stringent fluid management might help to prevent postoperative ileus after loop ileostomy closure. Langenbecks Arch Surg. 2019. https://doi.org/10.1007/s00423-018-1744-4 .
doi: 10.1007/s00423-018-1744-4
pubmed: 30607532
Feldheiser A, Aziz O, Baldini G, et al. Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: Consensus statement for anaesthesia practice. Acta Anaesthesiol Scand. 2016. https://doi.org/10.1111/AAS.12651 .
doi: 10.1111/AAS.12651
pubmed: 26514824
Fotopoulou C, Planchamp F, Aytulu T, et al. European society of gynaecological oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery. Int J Gynecol Cancer. 2021. https://doi.org/10.1136/ijgc-2021-002951 .
doi: 10.1136/ijgc-2021-002951
pubmed: 34795020
Kinnen A, Klaschik S, Neumann C, et al. Gene expression in the angiopoietin/TIE axis is altered in peripheral tissue of ovarian cancer patients: A prospective observational study. Life Sci. 2021. https://doi.org/10.1016/J.LFS.2021.119345 .
doi: 10.1016/J.LFS.2021.119345
pubmed: 33713666
Hasselgren E, Hertzberg D, Camderman T, Björne H, Salehi S. Perioperative fluid balance and major postoperative complications in surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2021. https://doi.org/10.1016/J.YGYNO.2021.02.034 .
doi: 10.1016/J.YGYNO.2021.02.034
pubmed: 33715894
Russo A, Aceto P, Grieco DL, et al. Goal-directed hemodynamic management in patients undergoing primary debulking gynaecological surgery: A matched-controlled precision medicine study. Gynecol Oncol. 2018. https://doi.org/10.1016/J.YGYNO.2018.08.034 .
doi: 10.1016/J.YGYNO.2018.08.034
pubmed: 30201234
Strong VE, Selby LV, Sovel M, et al. Development and assessment of memorial sloan kettering cancer center’s surgical secondary events grading system. Ann Surg Oncol. 2015. https://doi.org/10.1245/s10434-014-4141-4 .
doi: 10.1245/s10434-014-4141-4
pubmed: 26259755
Myles PS, Bellomo R, Corcoran T, et al. Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med. 2018. https://doi.org/10.1056/NEJMOA1801601 .
doi: 10.1056/NEJMOA1801601
pubmed: 30257158
Mayer J, Boldt J, Mengistu AM, Röhm KD, Suttner S. Goal-directed intraoperative therapy based on autocalibrated arterial pressure waveform analysis reduces hospital stay in high-risk surgical patients: a randomized, controlled trial. Crit Care. 2010. https://doi.org/10.1186/CC8875 .
doi: 10.1186/CC8875
pubmed: 20587008
Lindemann K, Kok PS, Stockler M, Jaaback K, Brand A. Enhanced recovery after surgery for advanced ovarian cancer: a systematic review of interventions trialed. Int J Gynecol Cancer. 2017. https://doi.org/10.1097/IGC.0000000000000981 .
doi: 10.1097/IGC.0000000000000981
pubmed: 28525497
Zajak J, Páral J, Sirový M, et al. Blood loss quantification during major abdominal surgery: prospective observational cohort study. BMC Surg. 2024. https://doi.org/10.1186/s12893-023-02288-w .
doi: 10.1186/s12893-023-02288-w
pubmed: 38166991
Hunsicker O, Fotopoulou C, Pietzner K, et al. Hemodynamic consequences of malignant ascites in epithelial ovarian cancer surgery: a prospective substudy of a randomized controlled trial. Medicine. 2015. https://doi.org/10.1097/MD.0000000000002108 .
doi: 10.1097/MD.0000000000002108
pubmed: 26656336
Aaen AA, Voldby AW, Storm N, et al. Goal-directed fluid therapy in emergency abdominal surgery: a randomised multicentre trial. Br J Anaesth. 2021. https://doi.org/10.1016/j.bja.2021.06.031 .
doi: 10.1016/j.bja.2021.06.031
pubmed: 34389168
Michard F, Lopes MR, Auler JOC. Pulse pressure variation: beyond the fluid management of patients with shock. Crit Care. 2007. https://doi.org/10.1186/cc5905 .
doi: 10.1186/cc5905
pubmed: 17822565
Lago V, Fotopoulou C, Chiantera V, et al. Risk factors for anastomotic leakage after colorectal resection in ovarian cancer surgery: a multi-centre study. Gynecol Oncol. 2019. https://doi.org/10.1016/j.ygyno.2019.03.241 .
doi: 10.1016/j.ygyno.2019.03.241
pubmed: 30952369
Namba Y, Hirata Y, Mukai S, et al. Clinical indicators for the incidence of postoperative ileus after elective surgery for colorectal cancer. BMC Surg. 2021. https://doi.org/10.1186/S12893-021-01093-7/FIGURES/2 .
doi: 10.1186/S12893-021-01093-7/FIGURES/2
pubmed: 33573636
VandeHei MS, Papageorge CM, Murphy MM, Kennedy GD. The effect of perioperative fluid management on postoperative ileus in rectal cancer patients. Surgery. 2017. https://doi.org/10.1016/J.SURG.2016.11.015 .
doi: 10.1016/J.SURG.2016.11.015
pubmed: 28139242
Marjanovic G, Villain C, Juettner E, et al. Impact of different crystalloid volume regimes on intestinal anastomotic stability. Ann Surg. 2009. https://doi.org/10.1097/SLA.0b013e31818b73dc .
doi: 10.1097/SLA.0b013e31818b73dc
pubmed: 19212167
Chiarello MM, Fransvea P, Cariati M, Adams NJ, Bianchi V, Brisinda G. Anastomotic leakage in colorectal cancer surgery. Surg Oncol. 2022. https://doi.org/10.1016/j.suronc.2022.101708 .
doi: 10.1016/j.suronc.2022.101708
pubmed: 35092916
Mandai R, Eguchi Y, Tanaka M, Sai Y, Nosaka S. Effects of profound hemodilution on small-intestinal wound healing in rabbits. J Surg Res. 2001. https://doi.org/10.1006/jsre.2001.6164 .
doi: 10.1006/jsre.2001.6164
pubmed: 11421611
Buchmiller-Crair TL, Kim CS, Won NH, Chopourian HL, Shaw KS, Fonkalsrud EW. Effect of acute anemia on the healing of intestinal anastomoses in the rabbit. J Trauma. 2001. https://doi.org/10.1097/00005373-200108000-00024 .
doi: 10.1097/00005373-200108000-00024
pubmed: 11493801
Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol. 2007. https://doi.org/10.1016/J.AJOG.2007.10.495 .
doi: 10.1016/J.AJOG.2007.10.495
pubmed: 18060979